TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trial.

Jeffrey M Burns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.